Bradykinin mediated laryngeal oedema due to angiotensin converting enzyme inhibitor;L'angiœdème laryngé induit par les médicaments interférant avec le métabolisme de la bradykinine

Revue Francaise d'Allergologie

Volumn 52, Issue 3, 2012, Pages 157-159

  Bouillet, L ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Angioedema; Angiotensin converting enzyme inhibitor; Asphyxia; Bradykinin

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; BRADYKININ; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CORTICOSTEROID THERAPY; DRUG FATALITY; HUMAN; LARYNX EDEMA;

EID: 84859727500     PISSN: 18770320     EISSN: 18770312     Source Type: Journal    
DOI: 10.1016/j.reval.2012.01.006     Document Type: Article

References (19)

1. Maurer M., Bader M., Bas M., Bossi F., Cicardi M., Cugno M., et al. New topics in bradykinin research. Allergy 2011, 66:1397-1406.
2. Cugno M., Nussberger J., Cicardi M., Agostini A. Bradykinin and the physiopathology of angioedema. Int Immunopharmacol 2003, 3:311-317.
3. Hoover T., Lippmann M., Grouzmann E., Marceau F., Herscu P. Angiotensin converting enzyme inhibitor-induced angioedema: a review of the pathophysiology and risk factors. Clin Exp Allergy 2009, 103:502-507.
4. Agostoni A., Cicardi M., Cugno M., Zingale L., Gioffre D., Nussberger J. Angioedema due to angiotensin converting enzyme inhibitors. Immunopharmacol 1999, 44:21-25.
5. Weber M., Messerli F. Angiotensin converting enzyme inhibitors and angioedema estimating the risk. Hypertens 2008, 51:1465-1467.
6. Kostis J., Packer M., Black H., Schmieder R., Henry D., Levy E. Omapatrilat and enalapril in patients with hypertension: the omapatrilat cardiovascular treatment vs. enalapril (OCTAVE) trial. Am J Hypertens 2004, 17:103-111.
7. Miller D., Oliveria S., Berlowitz D., Fincke B., Stang P., Lillienfeld D. Angioedema incidence in US veterans initiating angiotensin converting enzyme inhibitors. Hypertens 2008, 51:1-2.
8. Agostoni A., Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001, 24:599-606.
9. Cilia La Corte A., Carter A., Rice G., Duan Q.L., Rouleau G., Adam A., et al. A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema. Hum Mutat 2011, 32:1326-1331.
10. Brown N., Byiers S., Carr D., Maldonado M., Warner B. Dipeptidyl peptidase IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertens 2009, 54:516-523.
11. Duerr M., Glander P., Diekmann F., Dragun D., Neumayer H., Budde K. Increased Incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients. Clin J Am Soc Nephrol 2010, 5:703-708.
12. Ottomeyer C., Sick C., Hennerici M.G., Szabo K. Orolingual angioedema under systemic thrombolysis with rt-PA: an underestimated side effect. Nervenarzt 2009, 80:459-463.
13. Bas M., Hoffmann T., Bier H., Kojda G. Increased C-reactive protein in ACE inhibitor-induced angioedema. Br J Clin Pharmacol 2004, 59:233-238.
14. Beltrami L., Zanichelli A., Zingale L., Vacchinib R., Carugo S., Cicardi M. Long-term follow-up of 111 patients with angiotensin converting enzyme inhibitor-related angioedema. J Hypertens 2011, 29:2273-2277.
15. Dobbels P., Van Overbeke L., Vanbeckevoort D., Hiele M. Acute abdomen due to intestinal angioedema induced by ACE inhibitors: not so rare. Acta Gastroenterol Belg 2009, 72:455-457.
16. Bas M., Greve J., Stelter K., Bier H., Stark T., Hoffmann T., et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin converting enzyme inhibitors: a case series. Ann Emerg Med 2010, 56:278-282.
17. Gelée B., Michel P., Haas P., Boishardy F. Angiotensin converting enzyme inhibitor-related angioedema: treatment in an emergency room with complement C1 inhibitor concentrate. Rev Med Intern 2007, 29:516-519.
18. Brown N.J., Snowden M., Griffin M.R. Recurrent angiotensin converting enzyme inhibitor- associated angioedema. JAMA 1997, 278:232-233.
19. Haymore B.R., Yoon J., Mikita C.P., Klote M.M., DeZee K.J. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin converting enzyme inhibitors: a meta-analysis. Ann Allergy Asthma Immunol 2008, 101:495-499.